Insulet Other Non Cash Items Over Time
| PODD Stock | USD 266.57 10.01 3.90% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Insulet Performance and Insulet Correlation. Insulet |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.46 | Earnings Share 5.86 | Revenue Per Share 28.341 | Quarterly Revenue Growth 0.257 | Return On Assets 0.0757 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Non Cash Items Analysis
Compare Insulet and related stocks such as DexCom Inc, Integra LifeSciences, and Senseonics Holdings Other Non Cash Items Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IART | 19.3 M | 13.3 M | (21.7 M) | 57.5 M | 9.5 M | 30.6 M | (30.4 M) | 7.9 M | 13.8 M | 226.3 M | 39.8 M | (28.1 M) | (18.1 M) | 22 M | 18.7 M |
| SENS | 1 M | 1 M | 1 M | 1 M | 67 K | 77 K | 252 K | 453 K | 3.3 M | 8.5 M | 23.7 M | 8.5 M | (215.6 M) | (15.8 M) | (16.5 M) |
| TNDM | 544 K | 544 K | 1.1 M | 25 K | 260 K | 215 K | 1.1 M | 3.7 M | 76.3 M | (321 K) | 28.9 M | 2.3 M | 50.5 M | 104.7 M | 109.9 M |
| ABT | 5.1 M | (967.9 B) | (1.8 T) | (391 M) | (342 M) | (539 M) | 1.4 B | 912 M | 32 M | 247 M | 425 M | 55 M | 215 M | 126 M | 132.3 M |
| ALGN | 1.4 M | (11.3 M) | 21.4 M | 44.1 M | (11.3 M) | 3.4 M | (3.1 M) | 17.1 M | 25.9 M | 61.8 M | 56.2 M | 7.8 M | 71.8 M | 70.8 M | 74.4 M |
| SYK | 2.8 M | 165 M | 39 M | (49 M) | (107 M) | (173 M) | (51 M) | (149 M) | 1.5 B | (253 M) | (190 M) | 66 M | (226 M) | 19 M | 18.1 M |
| PEN | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | 1.9 M | 1.6 M | 4 M | 4.2 M | 38 M | 5.1 M | 17.6 M | 9.2 M | 5 M | 26.8 M | 28.1 M |
| TMDX | 65 K | 65 K | 65 K | 65 K | 65 K | 65 K | 65 K | 93 K | 177 K | 475 K | 511 K | 1.4 M | 3.4 M | 30 M | 31.5 M |
| MASI | 200 K | 4.9 M | 3.9 M | 2.3 M | 1.3 M | (2.1 M) | 644 K | 11.2 M | (1.5 M) | 1 M | 636 K | 1.3 M | 3.3 M | 13.8 M | 14.5 M |
| INSP | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K | 180 K | 315 K | 714 K | 1.3 M | 1.4 M | 1.4 M | 812 K | 1.3 M | 901.1 K |
| NARI | 106 K | 106 K | 106 K | 106 K | 106 K | 106 K | 106 K | 106 K | 106 K | 101 K | 181 K | 143 K | 973 K | (15.6 M) | (14.8 M) |
| INMD | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 8.2 M | (754 K) | (178 K) | 1.9 M | (690 K) | (3.7 M) | (3.5 M) |
| GKOS | (1.8 M) | (1.8 M) | (1.8 M) | 24 K | (33 K) | 298 K | (31 K) | 722 K | 1.9 M | 8.7 M | 31.7 M | 7.2 M | 5.1 M | 5.7 M | 5.5 M |
Insulet and related stocks such as DexCom Inc, Integra LifeSciences, and Senseonics Holdings Other Non Cash Items description
My Equities
My Current Equities and Potential Positions
| Insulet | PODD |
| Classification | Obamacare Repeal |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 266.57
Check out Insulet Performance and Insulet Correlation. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Insulet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.